These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9472783)

  • 1. Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody.
    Konishi H; Ochiya T; Chester KA; Begent RH; Muto T; Sugimura T; Terada M
    Hum Gene Ther; 1998 Jan; 9(2):235-48. PubMed ID: 9472783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase.
    Khare PD; Shao-Xi L; Kuroki M; Hirose Y; Arakawa F; Nakamura K; Tomita Y; Kuroki M
    Cancer Res; 2001 Jan; 61(1):370-5. PubMed ID: 11196189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward targeted killing of tumor-specific antigen-producing cancer cells by retrovirus displaying a single chain variable fragment antibody.
    Konishi H; Ochiya T; Muto T; Sugimura T; Terada M
    Adv Exp Med Biol; 1998; 451():405-10. PubMed ID: 10026903
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies.
    Aires da Silva F; Costa MJ; Corte-Real S; Goncalves J
    Hum Gene Ther; 2005 Feb; 16(2):223-34. PubMed ID: 15761262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA.
    Kuroki M; Arakawa F; Khare PD; Kuroki M; Liao S; Matsumoto H; Abe H; Imakiire T
    Anticancer Res; 2000; 20(6A):4067-71. PubMed ID: 11131674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors.
    Chowdhury S; Chester KA; Bridgewater J; Collins MK; Martin F
    Mol Ther; 2004 Jan; 9(1):85-92. PubMed ID: 14741781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell-specific gene transfer with retroviral vectors displaying single-chain antibody.
    Tang Y; Li Y; Qian G
    Chin Med J (Engl); 2002 Jul; 115(7):1064-9. PubMed ID: 12150744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.
    Benedict CA; Tun RY; Rubinstein DB; Guillaume T; Cannon PM; Anderson WF
    Hum Gene Ther; 1999 Mar; 10(4):545-57. PubMed ID: 10094198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells.
    Pizzato M; Blair ED; Fling M; Kopf J; Tomassetti A; Weiss RA; Takeuchi Y
    Gene Ther; 2001 Jul; 8(14):1088-96. PubMed ID: 11526456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.
    Nguyen TH; Loux N; Dagher I; Vons C; Carey K; Briand P; Hadchouel M; Franco D; Jouanneau J; Schwall R; Weber A
    Cancer Gene Ther; 2003 Nov; 10(11):840-9. PubMed ID: 14605670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells.
    Hombach A; Schneider C; Sent D; Koch D; Willemsen RA; Diehl V; Kruis W; Bolhuis RL; Pohl C; Abken H
    Int J Cancer; 2000 Oct; 88(1):115-20. PubMed ID: 10962448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity.
    Arakawa F; Shibaguchi H; Xu Z; Kuroki M
    Anticancer Res; 2002; 22(6C):4285-9. PubMed ID: 12553071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.
    Tanaka T; Kanai F; Okabe S; Yoshida Y; Wakimoto H; Hamada H; Shiratori Y; Lan K; Ishitobi M; Omata M
    Cancer Res; 1996 Mar; 56(6):1341-5. PubMed ID: 8640823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells.
    Ojala K; Mottershead DG; Suokko A; Oker-Blom C
    Biochem Biophys Res Commun; 2001 Jun; 284(3):777-84. PubMed ID: 11396970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vectors displaying functional antibody fragments.
    Russell SJ; Hawkins RE; Winter G
    Nucleic Acids Res; 1993 Mar; 21(5):1081-5. PubMed ID: 8385311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific transcriptional targeting of suicide gene therapy.
    Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
    Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen.
    Arakawa F; Haruno M; Kuroki M; Kanda H; Watanabe T; Misumi Y; Matsuoka Y
    Hybridoma; 1993 Aug; 12(4):365-79. PubMed ID: 8244416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.